Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Memphasys (ASX: MEM) June Quarter Review: International Expansion and Revenue Momentum

Memphasys Limited (ASX: MEM) entered the final quarter of FY26 with increased commercial activity across multiple international markets, supported by higher revenue, additional supply agreements and progress in the global rollout of its Felix™ sperm separation technology. The healthcare company also reported improved liquidity, …

Sonal Goyal | 16 July 2026

Integral Diagnostics (ASX:IDX) Shares Tick Higher Amid Positive Momentum in the Healthcare Sector

Integral Diagnostics Ltd (ASX:IDX) traded higher during the afternoon trading session on 16 July 2026, with its shares rising 1.90% to AUD 2.14. While the latest session reflected positive market sentiment, the stock remains 19.55% lower over the past year, illustrating the difference between …

Aditi Sarkar | 16 July 2026

ResMed (ASX: RMD) CEO Among Highest-Paid On The ASX, Topping AUD 30m

Executive remuneration has once again become a major talking point for investors, with ResMed Inc. (ASX: RMD) featuring among ASX-listed companies whose chief executives receive the largest compensation packages. Reports indicate the company's US-based CEO received remuneration exceeding AUD 30m, highlighting the growing focus …

Aditi Sarkar | 16 July 2026

Should You Consider Ramsay Health Care for Your Portfolio?

Ramsay Health Care operates private hospitals and healthcare facilities across Australia and several international markets including the United Kingdom, France and other parts of Europe, providing a broad range of surgical, medical and psychiatric care services.

Sonal Goyal | 15 July 2026

Why Is ResMed Stock Down Today?

ResMed designs and manufactures medical devices for the treatment of sleep apnea and other respiratory conditions, including continuous positive airway pressure (CPAP) machines and related masks and accessories, serving patients and healthcare providers globally.

Sonal Goyal | 15 July 2026

Should You Consider Sigma Healthcare for Your Portfolio?

Sigma Healthcare operates a pharmacy wholesaling and distribution business, supplying pharmaceutical products to retail pharmacies across Australia, and following its merger with Chemist Warehouse Group, now also encompasses one of the country's largest retail pharmacy networks.

Sonal Goyal | 15 July 2026

What's Behind Telix Pharmaceuticals' Decline?

Telix Pharmaceuticals develops radiopharmaceutical products used in both the diagnosis and treatment of cancer and other diseases, with its lead commercial product used in prostate cancer imaging, alongside a broader pipeline of diagnostic and therapeutic radiopharmaceutical candidates targeting various cancer types.

Sonal Goyal | 15 July 2026

Why Is Pro Medicus Stock Down Today?

Pro Medicus develops and licenses radiology imaging software, including its Visage platform used by hospitals, imaging centres and healthcare providers globally to view, process and manage medical images such as X-rays, CT scans and MRIs.

Sonal Goyal | 15 July 2026

Is Regis Healthcare Worth a Look After This Decline?

Regis Healthcare operates residential aged care facilities across Australia, providing accommodation and care services for elderly residents, operating within a sector that has undergone significant regulatory reform in recent years following government reviews into aged care quality and funding.

Sonal Goyal | 15 July 2026

Is Fisher & Paykel Healthcare a Stock Worth Watching?

Fisher & Paykel Healthcare designs and manufactures respiratory humidification and acute care medical devices, including products used in hospital respiratory support, sleep apnea treatment and surgical humidification, serving healthcare providers across numerous international markets from its New Zealand manufacturing base.

Sonal Goyal | 15 July 2026
Support

Hi! How can we help you today?

Loading…